New Research Shows COVID-19 Vaccines Still Protect Heart Health

New research suggests that updated COVID-19 vaccines continue to offer important protection for heart health. While many people have stopped getting seasonal COVID-19 shots, recent studies indicate that these vaccines still play a vital role in preventing serious cardiovascular events. These events include heart attacks, strokes, and hospitalizations for heart failure. According to MedPage Today, these findings are particularly relevant for older adults and those with existing health conditions.

The research, published in JAMA Internal Medicine, examined data from more than one million veterans. The study compared patients who received the 2024-2025 COVID-19 vaccine with those who did not. According to Ars Technica, the researchers found that the vaccine was about 38 percent effective at preventing major heart-related problems associated with COVID-19. While the overall benefit might seem modest, it represents a clear reduction in risk for those who choose to get vaccinated.

Dr. Ziyad Al-Aly of the VA St. Louis Health Care System and his team noted that the vaccines are especially helpful for people over the age of 75. In this specific group, the vaccine effectiveness was over 50 percent. This is a significant finding because older adults are often at a higher risk of severe illness if they contract the virus. The study showed that for every 10,000 people, the number of serious heart events dropped among those who were vaccinated compared to those who were not.

Beyond heart health, other research confirms that the vaccines remain effective against the virus itself. A study led by Dr. Ryan Wiegand of the CDC’s National Center for Immunization and Respiratory Diseases found that the 2024-2025 vaccines provided protection against emergency room visits, hospital stays, and critical illness. According to MedPage Today, the vaccines were 35 percent effective against hospitalization and 41 percent effective against critical illness. These results were consistent for people aged 65 and older.

These findings are important because the virus has changed significantly since the start of the pandemic. As the virus evolves, scientists update the vaccines to better match the new versions of the virus. Some people may wonder if the vaccines are still necessary now that many people have some level of immunity from past infections or previous shots. However, the researchers emphasize that vaccination continues to provide a meaningful layer of protection. It is not just about preventing the infection itself, but about reducing the chances of severe outcomes that can damage the heart and other organs.

For doctors and other medical professionals, these results provide a clear message. According to MedPage Today, the study authors wrote that annual COVID-19 vaccination continues to reduce the risk of severe health problems. This is especially true in the first six months after receiving the shot. The data suggests that for patients at the highest risk, staying up to date with vaccinations is a simple but effective way to protect their long-term health.

While the benefits of the vaccines are clear, the researchers also noted that the level of protection is not exactly the same as it was during the early stages of the pandemic. This is expected as the virus changes and as immunity levels in the general population shift. Nevertheless, the evidence remains strong that the vaccines are a valuable tool for public health. As we look toward future seasons, these studies suggest that the strategy of using updated, annual shots will remain a key part of keeping people safe from the most dangerous effects of COVID-19.

In summary, the latest data provides a strong reason for older adults and those with health concerns to consider getting their seasonal vaccines. By lowering the risk of heart-related complications and severe illness, the vaccines help maintain overall health and reduce the burden on hospitals. As more research becomes available, experts will continue to monitor how these vaccines perform, but current evidence clearly supports their continued use as a protective measure against the ongoing threat of the virus.